Reuters logo
BRIEF-Pharming Submits License Application to FDA for Ruconest
November 27, 2017 / 6:09 AM / 21 days ago

BRIEF-Pharming Submits License Application to FDA for Ruconest

Nov 27 (Reuters) - PHARMING GROUP NV:

* PHARMING SUBMITS SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION TO FDA FOR RUCONEST® FOR PROPHYLAXIS OF HEREDITARY ANGIOEDEMA ATTACKS

* ‍TWO STUDIES ENROLLED A TOTAL OF 56 PATIENTS AND SHOWED CONSISTENT EFFICACY AND SAFETY RESULTS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below